Ricky Zipp
Editor at Informa TechTarget
Health Analyst for @MorningConsult | Living in NYC | Science Master from Medill
Articles
-
1 day ago |
medtechdive.com | Ricky Zipp
This audio is auto-generated. Please let us know if you have feedback.
-
6 days ago |
supplychaindive.com | Ricky Zipp
This audio is auto-generated. Please let us know if you have feedback. By the numbersMedtech Q1 sales: $8.02 billion2.5% increase year over yearCardiovascular: $2.1 billion16.4% increase year over yearOrthopedics: $2.24 billion4.2% decrease year over yearJohnson & Johnson CFO Joe Wolk said Tuesday that the White House’s flurry of tariff actions will result in an approximately $400 million charge this year, primarily affecting the company’s medtech business.
-
1 week ago |
manufacturingdive.com | Ricky Zipp
This audio is auto-generated. Please let us know if you have feedback. Johnson & Johnson CFO Joe Wolk said Tuesday that the White House’s flurry of tariff actions will result in an approximately $400 million charge this year, primarily affecting the company’s medtech business. Wolk first revealed the impact to J&J’s 2025 guidance Tuesday morning on CNBC.
-
1 week ago |
medtechdive.com | Ricky Zipp
This audio is auto-generated. Please let us know if you have feedback. Johnson & Johnson failed to capitalize on the pulsed field ablation wave in the first quarter of 2025, despite recently launching its Varipulse device in the U.S.The healthcare giant on Tuesday reported strong growth for its cardiovascular portfolio — largely due to its recent M&A spree in the space — but electrophysiology sales fell year over year by nearly 2%.
-
1 week ago |
medtechdive.com | Ricky Zipp
This audio is auto-generated. Please let us know if you have feedback. By the numbersMedtech Q1 sales: $8.02 billion2.5% increase year over yearCardiovascular: $2.1 billion16.4% increase year over yearOrthopedics: $2.24 billion4.2% decrease year over yearJohnson & Johnson CFO Joe Wolk said Tuesday that the White House’s flurry of tariff actions will result in an approximately $400 million charge this year, primarily affecting the company’s medtech business.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 765
- Tweets
- 1K
- DMs Open
- No
RT @ktkadakia: 6 ways the FDA can improve medical device recalls -- great write-up by @EliseReuter today in @MedTechDive on the breadth of…
RT @alexandraandnyc: Overheard in the newsroom: "It's a beautiful day outside. Life is being lived while we write up earnings."
RT @saleyley: Earlier this week, @IMAX reported significant growth in its latest quarter. For @FastCompany, I took a deep dive into the suc…